| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |